Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
MeritCare Bemidji
mi
from
Bemidji, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
MeritCare Bemidji
mi
from
Bemidji, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Fairview Ridges Hospital
mi
from
Burnsville, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Fairview Ridges Hospital
mi
from
Burnsville, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Mercy and Unity Cancer Center at Mercy Hospital
mi
from
Coon Rapids, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Mercy and Unity Cancer Center at Mercy Hospital
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Duluth Clinic Cancer Center - Duluth
mi
from
Duluth, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Duluth Clinic Cancer Center - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
CCOP - Duluth
mi
from
Duluth, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Miller - Dwan Medical Center
mi
from
Duluth, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Miller - Dwan Medical Center
mi
from
Duluth, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Fairview Southdale Hospital
mi
from
Edina, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Fairview Southdale Hospital
mi
from
Edina, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Fergus Falls Medical Group, PA
mi
from
Fergus Falls, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Fergus Falls Medical Group, PA
mi
from
Fergus Falls, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Mercy and Unity Cancer Center at Unity Hospital
mi
from
Fridley, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Mercy and Unity Cancer Center at Unity Hospital
mi
from
Fridley, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Hutchinson Area Health Care
mi
from
Hutchinson, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Hutchinson Area Health Care
mi
from
Hutchinson, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
HealthEast Cancer Care at St. John's Hospital
mi
from
Maplewood, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
HealthEast Cancer Care at St. John's Hospital
mi
from
Maplewood, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Minnesota Oncology Hematology PA-Maplewood
mi
from
Maplewood, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Minnesota Oncology Hematology PA-Maplewood
mi
from
Maplewood, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
mi
from
Minneapolis, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Hennepin County Medical Center - Minneapolis
mi
from
Minneapolis, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Hennepin County Medical Center - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center
mi
from
Robbinsdale, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center
mi
from
Robbinsdale, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
CentraCare Clinic - River Campus
mi
from
Saint Cloud, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
CentraCare Clinic - River Campus
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Coborn Cancer Center
mi
from
Saint Cloud, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Coborn Cancer Center
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Park Nicollet Cancer Center
mi
from
Saint Louis Park, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Park Nicollet Cancer Center
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
United Hospital
mi
from
Saint Paul, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
United Hospital
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
St. Francis Cancer Center at St. Francis Medical Center
mi
from
Shakopee, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
St. Francis Cancer Center at St. Francis Medical Center
mi
from
Shakopee, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Ridgeview Medical Center
mi
from
Waconia, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Ridgeview Medical Center
mi
from
Waconia, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
CCOP - Cancer Research for the Ozarks
mi
from
Springfield, MO
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
CCOP - Cancer Research for the Ozarks
mi
from
Springfield, MO
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
St. John's Regional Health Center
mi
from
Springfield, MO
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
St. John's Regional Health Center
mi
from
Springfield, MO
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Hulston Cancer Center at Cox Medical Center South
mi
from
Springfield, MO
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Hulston Cancer Center at Cox Medical Center South
mi
from
Springfield, MO
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
CCOP - Montana Cancer Consortium
mi
from
Billings, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
CCOP - Montana Cancer Consortium
mi
from
Billings, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Hematology-Oncology Centers of the Northern Rockies - Billings
mi
from
Billings, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Hematology-Oncology Centers of the Northern Rockies - Billings
mi
from
Billings, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Northern Rockies Radiation Oncology Center
mi
from
Billings, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Northern Rockies Radiation Oncology Center
mi
from
Billings, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
St. Vincent Healthcare Cancer Care Services
mi
from
Billings, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
St. Vincent Healthcare Cancer Care Services
mi
from
Billings, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Billings Clinic - Downtown
mi
from
Billings, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Billings Clinic - Downtown
mi
from
Billings, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Bozeman Deaconess Cancer Center
mi
from
Bozeman, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Bozeman Deaconess Cancer Center
mi
from
Bozeman, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
St. James Healthcare Cancer Care
mi
from
Butte, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
St. James Healthcare Cancer Care
mi
from
Butte, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Great Falls Clinic - Main Facility
mi
from
Great Falls, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Great Falls Clinic - Main Facility
mi
from
Great Falls, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Great Falls, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Great Falls, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Northern Montana Hospital
mi
from
Havre, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Northern Montana Hospital
mi
from
Havre, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
St. Peter's Hospital
mi
from
Helena, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
St. Peter's Hospital
mi
from
Helena, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Glacier Oncology, PLLC
mi
from
Kalispell, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Glacier Oncology, PLLC
mi
from
Kalispell, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Kalispell Medical Oncology at KRMC
mi
from
Kalispell, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Kalispell Medical Oncology at KRMC
mi
from
Kalispell, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Kalispell Regional Medical Center
mi
from
Kalispell, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Community Medical Center
mi
from
Missoula, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Community Medical Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Guardian Oncology and Center for Wellness
mi
from
Missoula, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Guardian Oncology and Center for Wellness
mi
from
Missoula, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Montana Cancer Specialists at Montana Cancer Center
mi
from
Missoula, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Montana Cancer Specialists at Montana Cancer Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Montana Cancer Center
mi
from
Missoula, MT
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Montana Cancer Center
mi
from
Missoula, MT
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Cancer Resource Center - Lincoln
mi
from
Lincoln, NE
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Cancer Resource Center - Lincoln
mi
from
Lincoln, NE
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Immanuel Medical Center
mi
from
Omaha, NE
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Immanuel Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Alegent Health Cancer Center at Bergan Mercy Medical Center
mi
from
Omaha, NE
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Alegent Health Cancer Center at Bergan Mercy Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated:  12/31/1969
Creighton University Medical Center
mi
from
Omaha, NE
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Phase II Trial of Bevacizumab in Combination With Sorafenib in Recurrent Glioblastoma Multiforme
Status: Enrolling
Updated: 12/31/1969
Creighton University Medical Center
mi
from
Omaha, NE
Click here to add this to my saved trials